You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,067,522


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,067,522
Title:2,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
Abstract:Pyrimidine derivatives of formula (I) wherein Q.sub.1, Q.sub.2, G and R.sup.1 are as defined within; and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine/threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are also described.
Inventor(s): Pease; Elizabeth Janet (Macclesfield, GB), Williams; Emma Jane (Macclesfield, GB), Bradbury; Robert Hugh (Macclesfield, GB), Pearson; Stuart Eric (Macclesfield, GB)
Assignee: AstraZeneca AB (Sodertalje, SE)
Application Number:10/995,931
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,067,522

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to fully comprehend its implications and validity. This article will provide a detailed analysis of United States Patent 7,067,522, focusing on its claims, scope, and the relevant patent landscape.

What is a Patent?

Before diving into the specifics of the patent in question, it is essential to understand what a patent is. A patent is a form of intellectual property that gives its owner the legal right to exclude others from making, using, selling, and importing an invention for a certain period of time, usually 20 years from the filing date of the patent application[2].

Patent 7,067,522 Overview

To analyze the scope and claims of United States Patent 7,067,522, one must first identify the key elements of the patent.

Invention Description

The patent describes an invention related to a specific technological or scientific innovation. Understanding the core of the invention is vital for determining the patent's scope and claims.

Claims

Patent claims are the most critical part of a patent as they define the scope of protection. Claims must be clear, concise, and supported by the description in the patent specification. The claims of Patent 7,067,522 would outline what is considered novel and non-obvious about the invention[3].

Analyzing Patent Claims

Independent and Dependent Claims

Patent claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. Analyzing the structure and content of these claims helps in understanding the patent's scope.

Claim Language and Scope

The language used in the claims is crucial. Broader claims may cover a wider range of applications but risk being invalidated if they are too vague or overly broad. Narrower claims, while more specific, may offer stronger protection but limit the scope of the invention. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Scope and Its Metrics

Independent Claim Length and Count

Metrics such as independent claim length and count can be used to measure patent scope. Studies have indicated that these metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Examination Process Impact

The patent examination process often narrows the scope of patent claims. This is because examiners may require claim amendments to ensure the claims are novel, non-obvious, and clearly defined. The duration of the examination process can significantly impact the final scope of the patent claims[3].

Patent Landscape and Related Patents

Patent Family and Continuations

Understanding the patent family and any continuations or continuations-in-part is essential. This includes identifying other patents that may be related to Patent 7,067,522, such as parent patents, divisional patents, or patents that claim priority from the same application. The case of In re Cellect LLC highlights the complexities of patent families and the impact of obviousness-type double patenting (ODP) on patent validity[1].

Global Dossier and International Search

Using tools like the Global Dossier and international patent databases can help identify related patents filed in other jurisdictions. This is crucial for understanding the global patent landscape and potential overlaps or conflicts with other patents[4].

Obviousness-Type Double Patenting (ODP)

ODP is a critical issue in patent law that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA) or other factors. The In re Cellect LLC case illustrates how ODP can lead to the invalidation of claims if not properly addressed[1].

Practical Implications and Strategies

Conducting a Preliminary Patent Search

Before filing or analyzing a patent, conducting a thorough preliminary search is essential. Tools like the USPTO's Patent Public Search, Global Dossier, and international databases can help identify prior art and related patents[4].

Managing Patent Term Adjustments

Understanding how Patent Term Adjustments (PTA) and terminal disclaimers can affect the patent term is vital. As seen in the In re Cellect LLC case, these adjustments can have significant implications for the validity and scope of patent claims[1].

Key Takeaways

  • Clear and Concise Claims: Ensure that patent claims are clear, concise, and supported by the patent specification to avoid invalidation.
  • Patent Scope Metrics: Use metrics like independent claim length and count to measure and optimize patent scope.
  • Examination Process: Be prepared for the examination process to narrow the scope of patent claims.
  • ODP Considerations: Address ODP issues proactively to avoid claim invalidation.
  • Global Patent Landscape: Use global databases to identify related patents and understand the international patent landscape.

FAQs

  1. What is the purpose of independent and dependent claims in a patent?

    • Independent claims define the invention and stand alone, while dependent claims further limit the independent claims and provide additional specificity.
  2. How does the patent examination process affect the scope of patent claims?

    • The examination process often narrows the scope of patent claims through amendments required by examiners to ensure novelty, non-obviousness, and clarity.
  3. What is obviousness-type double patenting (ODP), and why is it important?

    • ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent filed at the same time but with a different patent term due to PTA or other factors.
  4. How can one measure the scope of a patent?

    • Metrics such as independent claim length and count can be used to measure patent scope and have explanatory power for several correlates of patent scope.
  5. What tools are available for searching and analyzing patents globally?

    • Tools like the USPTO's Patent Public Search, Global Dossier, and international databases such as those from the EPO, JPO, and WIPO can be used to search and analyze patents globally.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USAGov.
  3. Patent Claims and Patent Scope, SSRN, September 29, 2016.
  4. Search for patents, USPTO.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,067,522

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,067,522

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0004887Mar 01, 2000

International Family Members for US Patent 7,067,522

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 472537 ⤷  Subscribe
Australia 2001233979 ⤷  Subscribe
Australia 3397901 ⤷  Subscribe
Brazil 0108879 ⤷  Subscribe
Brazil 122014024864 ⤷  Subscribe
Canada 2398887 ⤷  Subscribe
China 1220684 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.